Correlation Between Structure Therapeutics and PTC Therapeutics
Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and PTC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and PTC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Structure Therapeutics American and PTC Therapeutics, you can compare the effects of market volatilities on Structure Therapeutics and PTC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of PTC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and PTC Therapeutics.
Diversification Opportunities for Structure Therapeutics and PTC Therapeutics
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Structure and PTC is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and PTC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PTC Therapeutics and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with PTC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PTC Therapeutics has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and PTC Therapeutics go up and down completely randomly.
Pair Corralation between Structure Therapeutics and PTC Therapeutics
Given the investment horizon of 90 days Structure Therapeutics American is expected to under-perform the PTC Therapeutics. In addition to that, Structure Therapeutics is 1.2 times more volatile than PTC Therapeutics. It trades about -0.04 of its total potential returns per unit of risk. PTC Therapeutics is currently generating about 0.11 per unit of volatility. If you would invest 3,519 in PTC Therapeutics on August 28, 2024 and sell it today you would earn a total of 780.00 from holding PTC Therapeutics or generate 22.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Structure Therapeutics America vs. PTC Therapeutics
Performance |
| Timeline |
| Structure Therapeutics |
| PTC Therapeutics |
Structure Therapeutics and PTC Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Structure Therapeutics and PTC Therapeutics
The main advantage of trading using opposite Structure Therapeutics and PTC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, PTC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PTC Therapeutics will offset losses from the drop in PTC Therapeutics' long position.| Structure Therapeutics vs. Eliem Therapeutics | Structure Therapeutics vs. Scpharmaceuticals | Structure Therapeutics vs. Milestone Pharmaceuticals | Structure Therapeutics vs. Seres Therapeutics |
| PTC Therapeutics vs. Krystal Biotech | PTC Therapeutics vs. Sarepta Therapeutics | PTC Therapeutics vs. Iovance Biotherapeutics | PTC Therapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |